drugset / Trial / NCT05298098

Impact of Hypertonic Saline Solution on Acute Decompensated Heart Failure

NCT05298098

Unknown 600 enrolled University of Monastir
RandomizedParallel-groupSingle-blindTreatment

Summary

Acute decompensated heart failure (HF) is one of the most common cardiologic issues in emergency departments. Loop diuretics have long been recognized as the key for the treatment of Acute Decompensated Heart Failure (ADHF).However, chronic treatment with diuretics may limit their response and deteriorates the renal function. The hypertonic saline solution (HSS) has been proposed in recent years as an adjunctive therapy for intravenous loop diuretics to improve or restore their initial pharmacological efficacy. In this study the investigators will evaluate the effectiveness of HSS as an adjunct to i.v. furosemide in patients admitted for AHF with renal dysfunction

Timeline

Start
2018-07-01
Primary completion
2023-09
Completion
2023-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hypertonic Saline Solution Unknown 10 % Intravenous
Comparator Hypertonic Saline Solution Unknown 50 ml Intravenous
Comparator Furosemide Other / unclassified 250 mg Intravenous

Indications